Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: Retrospective claims analysis

被引：0
|
作者：
Rachel Halpern
Sonalee Agarwal
Leigh Borton
Kathy Oneacre
Maria V. Lopez-Bresnahan
机构：
[1] OptumInsight,Health Economics and Outcomes Research
[2] Biogen Idec,Health Economics and Outcomes Research
[3] OptumInsight,undefined
[4] Medical and Scientific Affairs,undefined
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
drug therapy; medication adherence; medication persistence; multiple sclerosis; retrospective studies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：761 / 775
页数：14
相关论文
共 50 条
  • [31] Relapse rates among patients with multiple sclerosis who switch from interferon therapy to fingolimod or glatiramer acetate: a retrospective US claims database analysis
    Bergvall, N.
    Lahoz, R.
    Agashivala, N.
    Pradhan, A.
    Capkun-Niggli, G.
    Korn, J. R.
    Petrilla, A. A.
    Karkare, S. U.
    McGuiness, C. Balderston
    Makin, C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 276 - 276
  • [32] Erratum to: Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
    Katelyn R. Keyloun
    Ryan N. Hansen
    Zsolt Hepp
    Patrick Gillard
    Michael E. Thase
    Emily Beth Devine
    CNS Drugs, 2017, 31 : 511 - 511
  • [33] Measuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosis
    Lafata, Jennifer Elston
    Cerghet, Mirela
    Dobie, Elizabeth
    Schultz, Lonni
    Tunceli, Kaan
    Reuther, Jacqueline
    Elias, Stanton
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2008, 48 (06) : 752 - 757
  • [34] Training program for patients with multiple sclerosis at the start of immunomodulatory therapy
    Harto-Castano, Adela
    ENFERMERIA CLINICA, 2007, 17 (05): : 267 - 271
  • [35] Effects of immunomodulatory therapy on memory functioning in multiple sclerosis patients
    Drake, M
    Carra, A
    Allegri, R
    MULTIPLE SCLEROSIS, 2005, 11 : S72 - S72
  • [36] Effects of a Pharmaceutical Care program for patients with multiple sclerosis on adherence to immunomodulatory treatment
    Sanchez Casanueva, Tomas
    Tenias Burillo, Jose Maria
    Martinez Martinez, Fernando
    Valenzuela Gamez, Juan Carlos
    Navarro Maestre, Esther
    Calleja Hernandez, Miguel Angel
    ARS PHARMACEUTICA, 2014, 55 (01) : 38 - 44
  • [37] Adherence and compliance and related cognitive impairments in patients with multiple sclerosis on immunomodulatory treatment
    Dokova, Y.
    MULTIPLE SCLEROSIS, 2007, 13 : S237 - S237
  • [38] Effects of a Pharmaceutical Care program for patients with multiple sclerosis on adherence to immunomodulatory treatment
    Sanchez Casanueva, Tomas
    Maria Tenias Burillo, Jose
    Martinez Martinez, Fernando
    Carlos Valenzuela Gamez, Juan
    Navarro Maestre, Esther
    Angel Calleja Hernandez, Miguel
    ARS PHARMACEUTICA, 2013, 54 (04) : 2 - 8
  • [39] Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study
    Hansen, Kerstin
    Schuessel, Katrin
    Kieble, Marita
    Werning, Johanna
    Schulz, Martin
    Friis, Robert
    Poehlau, Dieter
    Schmitz, Norbert
    Kugler, Joachim
    PLOS ONE, 2015, 10 (07):
  • [40] Retrospective analysis of immunoglobulin therapy in a group of Portuguese multiple sclerosis patients
    Guimardes, J.
    Rio, M. E.
    Reis, J.
    Sa, M. J.
    MULTIPLE SCLEROSIS, 2006, 12 : S93 - S93
12345